Cerba Lancet Africa Group
Cerba Lancet Africa is the leading network of clinical pathology and biomedical laboratories in Africa, with the ambition to become the leading diagnostic services provider in Africa and world-class standards of pathology services to patients and medical communities across the continent. Cerba Lancet Africa is a joint venture created in 2019 with the French group Cerba HealthCare, a leading international player in medical diagnosis, and Lancet Laboratories, the foremost name in clinical pathology in sub-Saharan Africa.
Through the Joint Venture, Cerba Lancet Africa operates a network of more than 100 ISO-accredited laboratories across 14 African countries: Botswana, Eswatini, Ethiopia, Gabon, Ghana, Ivory Coast, Kenya, Mozambique, Nigeria, Rwanda, Tanzania, Uganda, Zambia and Zimbabwe.
“Our goal is to provide Africa with the best medical diagnostic solutions at world-class standards to improve the quality of life of communities.”
Tests in the Catalogue
Number of Sites
Average Monthly Number of Tests
Average Monthly Number of Patients
Our Mission
To be the leading force in local medical diagnostics in Africa, while offering the highest standards of pathology and biomedical services to patients and medical communities across the continent.
Our Vision
To provide Africa with the best medical diagnostic solutions at world-class standards to improve the quality of life of communities.
Our Values
Respect
Excellence
Commitment
Equity in Health
Latest News
HIV Integrase Inhibitors
Newsletters | 2022-12-02
Clinicians now have five classes of antiretroviral agents (ARVs) for the treatment of HIV infection in both treatment-naïve and treatment - experienced individuals.
Diabetes
Newsletters | 2022-11-02
Diabetes is a lifelong disease in which the body cannot process sugar properly. Diabetes is also called "diabetes mellitus" or "sugar diabetes". When people who have diabetes eat glucose, which is found in foods such as breads, potatoes and sweets, it can't be converted into energy. Instead of being converted into energy, the glucose stays in the blood.
Our Network



Ethiopia
- No. labs: N .C.
- * No. of patients: 24 200
- * No. of tests performed: 39 900

Gabon
- No. labs: N .C.
- * No. of patients: 2 800
- * No. of tests performed: 14 500

Ghana
- No. labs: 27
- * No. of patients: 39 000
- * No. of tests performed: 148 500


Kenya
- No. labs: 34
- * No. of patients: 32 000
- * No. of tests performed: 103 000

Nigeria
- No. labs: 11
- * No. of patients: 1 800
- * No. of tests performed: 53 000

Mozambique
- No. labs: 2
- * No. of patients: 1 300
- * No. of tests performed: 5 400

Rwanda
- No. labs: 5
- * No. of patients: 2 000
- * No. of tests performed: 8 000

Eswatini
- No. labs: 5
- * No. of patients: 6 200
- * No. of tests performed: 17 300

Tanzania
- No. labs: 10
- * No. of patients: 14 000
- * No. of tests performed: 75 000

Uganda
- No. labs: 21
- * No. of patients: 19 000
- * No. of tests performed: 77 000

Zambia
- No. labs: 4
- * No. of patients: 4 000
- * No. of tests performed: 12 500

Zimbabwe
- No. labs: 23
- * No. of patients: 24 000
- * No. of tests performed: 78 000
Current Network
- Botswana
- Ethiopia
- Gabon
- Ghana
- Ivory Coast
- Kenya
- Nigeria
- Mozambique
- Rwanda
- Eswatini
- Tanzania
- Uganda
- Zambia
- Zimbabwe